Steven Cohen’s Axonics, Inc. Common Stock AXNX Stock Holding History

Steven Cohen’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-658,695	Closed	-$37M	–	2971
2023 Q3	$37M	Buy	658,695 +600,821	+1,038%	+$33.8M	0.11%	240
2023 Q2	$2.92M	Sell	57,874 -1,012,626	-95%	-$53.9M	0.01%	964
2023 Q1	$58.4M	Buy	+1,070,500	New	+$62.5M	0.18%	143
2022 Q3	–	Sell	-497,446	Closed	-$28.2M	–	1798
2022 Q2	$28.2M	Buy	497,446 +278,060	+127%	+$15.2M	0.12%	233
2022 Q1	$13.7M	Buy	+219,386	New	+$11.8M	0.05%	424
2021 Q2	–	Sell	-165,787	Closed	-$9.93M	–	1212
2021 Q1	$9.93M	Buy	+165,787	New	+$9.01M	0.05%	427
2020 Q4	–	Sell	-530,819	Closed	-$27.1M	–	1187
2020 Q3	$27.1M	Buy	530,819 +31,248	+6%	+$1.3M	0.14%	206
2020 Q2	$17.5M	Sell	499,571 -364,150	-42%	-$12.5M	0.11%	234
2020 Q1	$21.9M	Buy	863,721 +574,502	+199%	+$17.1M	0.18%	164
2019 Q4	$8.01M	Buy	+289,219	New	+$6.9M	0.04%	413
2019 Q1	–	Sell	-282,608	Closed	-$4.27M	–	1279
2018 Q4	$4.27M	Buy	+282,608	New	+$4.21M	0.02%	590

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Steven Cohen's AXNX Position: Q4 2023 in Review

Steven Cohen sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2023, closing a stake of 658,695 shares — an estimated $37M sold.

Steven Cohen first reported a position in AXNX in Q4 2018 and held it in 11 quarters. The position peaked at $58.4M in Q1 2023. 230 funds tracked by Wall St. Rank hold AXNX as of Q4 2023.

Steven Cohen reported no remaining Axonics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Steven Cohen sold 658,695 Axonics, Inc. Common Stock shares in Q4 2023, an estimated $37M.
Steven Cohen first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 11 quarters.
Steven Cohen's Axonics, Inc. Common Stock position peaked at $58.4M in Q1 2023.
230 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.